Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/28/2002WO2002094836A2 Methods for preparation and use of psorospermin analogs
11/28/2002WO2002094835A1 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002WO2002094834A1 Imidazo [1,5-a] pyrimido [5,4-d] benzazepine derivatives as gaba a receptor modulators
11/28/2002WO2002094833A1 Novel pyrrole derivatives as pharmaceutical agents
11/28/2002WO2002094832A1 New benzylaminopyrimidines
11/28/2002WO2002094831A1 Novel pyridylmethylaminopyrimidines
11/28/2002WO2002094830A2 DIHYDROPYRROLO[1,2-A]INDOLE AND TETRAHYDROPYRIDO[1,2-a]-INDOLE DERIVATIVES AS PROSTAGLANDIN D2 RECEPTOR ANTAGONISTS
11/28/2002WO2002094828A1 Process for the preparation of imipenem
11/28/2002WO2002094826A1 Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists
11/28/2002WO2002094825A1 Novel spiropiperidine derivative
11/28/2002WO2002094823A1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
11/28/2002WO2002094821A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002WO2002094815A1 Process for the production of quinazolines
11/28/2002WO2002094814A1 3,5-diamino-1,2,4-triazoles as kinase inhibitors
11/28/2002WO2002094813A1 Novel pyridyl cyanoguanidine compounds
11/28/2002WO2002094812A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094811A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094810A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094808A1 Imidazole-2-carboxamide derivatives as raf kinase inhibitors
11/28/2002WO2002094805A1 Chiral compounds
11/28/2002WO2002094802A1 Substituted c-furan-2-yl-methylamine and c-thiophen-2-yl-methylamine derivatives
11/28/2002WO2002094799A2 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/28/2002WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002WO2002094794A1 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002WO2002094790A1 Fused heterocyclic compound and medicinal use thereof
11/28/2002WO2002094789A1 Quinoline derivatives as ligands for the neuropeptide y receptor
11/28/2002WO2002094788A1 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods
11/28/2002WO2002094787A1 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders
11/28/2002WO2002094786A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders
11/28/2002WO2002094785A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094784A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094783A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094782A1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094774A2 Oxcarbazepine dosage forms
11/28/2002WO2002094768A2 Aza hydroxylated ethyl amine compounds
11/28/2002WO2002094767A2 Trisubstituted-n-[(1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
11/28/2002WO2002094764A1 Anti-inflammatory and immunomodulatory amino acid derivatives, their preparation and use
11/28/2002WO2002094754A1 Vitamin d analogues
11/28/2002WO2002094745A2 Non-peptidic cyclophilin binding compounds and their use
11/28/2002WO2002094744A2 Compositions comprising d-chiro inositol and sulfonylureas and methods of treatment thereof
11/28/2002WO2002094379A1 Use and compositions of antiprogestins for treatment of prostate diseases
11/28/2002WO2002094325A2 Cytotoxic cd44 antibody immunoconjugates
11/28/2002WO2002094323A1 Weight reduction or weight controlling composition
11/28/2002WO2002094322A2 Combination medicament for treatment of neoplastic diseases containing cyanoguanidine ikk inhibitors and a second anti-neoplastic drug
11/28/2002WO2002094321A1 Compositions for promoting healing of bone fracture
11/28/2002WO2002094320A1 Therapeutic compositions for repairing chondropathy
11/28/2002WO2002094319A1 Preventive or recurrence-suppressive agents for liver cancer
11/28/2002WO2002094317A1 Methods and formulations of using a1 adenosine and p2x purinoreceptor antagonists
11/28/2002WO2002094311A1 Use of proteasome inhibitors to treat dry eye disorders
11/28/2002WO2002094309A1 Composition and methods for affecting metallocorrinoid uptake
11/28/2002WO2002094306A1 Remedies for nervous tumor
11/28/2002WO2002094301A1 Herbal drug composition for cartilage protection
11/28/2002WO2002094296A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/28/2002WO2002094292A1 Anti-ischemic and anti-reperfusion agents
11/28/2002WO2002094291A1 Composition and method for the treatment of pigmentation disorders
11/28/2002WO2002094289A1 Antiviral nucleoside derivatives
11/28/2002WO2002094288A1 Veterinary compositions comprising avermectin-oxime derivatives and praziquantel
11/28/2002WO2002094287A2 Identifying parasitic fungi of the organism, and treatment thereof
11/28/2002WO2002094286A1 Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives
11/28/2002WO2002094285A1 Single-daily-dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principle
11/28/2002WO2002094284A1 Method of treating dry eye disorders
11/28/2002WO2002094283A2 Use of phospholipids in the treatment of degenerative lung disease such as copd or cystic fibrosis and to enhance delivery of drugs
11/28/2002WO2002094282A2 Compositions with methylprednisolone derivatives having therapeutic effect
11/28/2002WO2002094281A1 Means and method for hormonal contraception
11/28/2002WO2002094280A1 Means and method for hormonal contraception
11/28/2002WO2002094279A1 Drug delivery system comprising a tetrahidroxilated estrogen for use in hormonal contraception
11/28/2002WO2002094278A1 Drug delivery system comprising a tetrahydroxylated estrogen for use in hormonal contraception
11/28/2002WO2002094277A1 Means and method for hormonal contraception
11/28/2002WO2002094276A1 Pharmaceutical composition for use in hormone replacement therapy
11/28/2002WO2002094275A1 Use of estrogen compounds to increase libido in women
11/28/2002WO2002094274A1 Cathartic composition
11/28/2002WO2002094273A2 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
11/28/2002WO2002094272A1 Analgesic composition and method
11/28/2002WO2002094271A1 Targeted delivery of bioaffecting compounds for the treatment of cancer
11/28/2002WO2002094270A2 Mip-1 alpha receptor ligands - drugs for t-cell mediated and autoimmune diseases
11/28/2002WO2002094269A1 Liposomally encapsulated hydrophobic active ingredients with a high active ingredient content ⊃ 50 % and method for the production of pharmaceutical preparations containing liposomally encapsulated hydrophobic active ingredients
11/28/2002WO2002094268A1 Tetrahydroquinolin derivatives for the inhibition of diseases associated with estrogen deprivation or with an aberrant physiological response to endogenous estrogen
11/28/2002WO2002094267A1 Pharmaceutical composition for prevention or treatment of arthritis
11/28/2002WO2002094266A1 Isoxazolone compounds useful in treating diseases associated with unwanted cytokine activity
11/28/2002WO2002094265A1 A method of modulating nf-$g(k)b activity
11/28/2002WO2002094264A1 Ccr4 antagonists
11/28/2002WO2002094263A2 Caspase inhibitors and uses thereof
11/28/2002WO2002094262A1 Heteroaryloxy 3-substituted propanamines s serotonin and norepinephrine reuptake inhibitors
11/28/2002WO2002094261A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound
11/28/2002WO2002094259A1 Compounds that inhibit hsp90 and stimulate hsp70 and hsp40, useful in the prevention or treatment of diseases associated with protein aggregation and amyloid formation
11/28/2002WO2002094257A1 Analgesic/antiinflammatory patches for topical use
11/28/2002WO2002094256A1 Lysine and/or analogues and/or polymers thereof for promoting wound healing and angiogenesis
11/28/2002WO2002094255A1 Method for the production of solid formulations of sodium 3-hydroxy-3-methylbutyrate
11/28/2002WO2002094254A2 Abuse resistant pharmaceutical composition containing capsaicin
11/28/2002WO2002094253A1 Agents for relieving eye controlling function error
11/28/2002WO2002094252A1 Preventive or remedy for diseases caused by cerebrovascular disturbances
11/28/2002WO2002094251A1 Compositions for the treatment of pigmentation disorders and methods for their manufacture
11/28/2002WO2002094249A1 Use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-d]pyrimidine for the treatment of pain
11/28/2002WO2002094248A2 Composition and use of substances for stabilising amino acids containing sulphur and/or for inhibiting the continuous formation of amino acids containing sulphur in a blood sample
11/28/2002WO2002094247A2 Use of a vitamin d3 analogue for the treatment of autoimmune diabetes
11/28/2002WO2002094246A2 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
11/28/2002WO2002094245A1 Delivery of antihistamines through an inhalation route
11/28/2002WO2002094244A2 Delivery of benzodiazepines through an inhalation route
11/28/2002WO2002094243A1 Delivery of sumatriptan, frovatriptan or naratriptan through an inhalation route
11/28/2002WO2002094242A1 Delivery of rizatriptan or zolmitriptan through an inhalation route
1 ... 5635 5636 5637 5638 5639 5640 5641 5642 5643 5644 5645 5646 5647 5648 5649 5650 5651 5652 5653 5654 5655 ... 7860